Cotrimoxazole prophylaxis is indicated at any CD4 in areas with high incidence of malaria and severe bacterial infections, and at CD4 below 350 cells/μL in other areas, but recommended at CD4 below 200 cells/μL in several countries [5, 8]. This evidence concerns the gene CD4 and malaria.